News
Aspira Pathlab & Diagnostics reports standalone net loss of Rs 0.69 crore in the March 2026 quarter
25-May-2026 | 07:43
Sales rise 12.80% to Rs 6.52 crore
Net loss of Aspira Pathlab & Diagnostics reported to Rs 0.69 crore in the quarter ended March 2026 as against net profit of Rs 0.72 crore during the previous quarter ended March 2025. Sales rose 12.80% to Rs 6.52 crore in the quarter ended March 2026 as against Rs 5.78 crore during the previous quarter ended March 2025.
For the full year,net profit declined 97.58% to Rs 0.05 crore in the year ended March 2026 as against Rs 2.07 crore during the previous year ended March 2025. Sales rose 13.55% to Rs 24.98 crore in the year ended March 2026 as against Rs 22.00 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 6.52 | 5.78 | 13 | 24.98 | 22.00 | 14 |
| OPM % | -5.06 | 18.17 | - | 5.84 | 16.00 | - |
| PBDT | -0.29 | 1.09 | PL | 1.59 | 3.56 | -55 |
| PBT | -0.69 | 0.72 | PL | 0.05 | 2.07 | -98 |
| NP | -0.69 | 0.72 | PL | 0.05 | 2.07 | -98 |
Powered by Capital Market - Live News
